Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
K. Hollevoet, J. Van Cleemput, J. Thimpont, M. Vandeweerdt, P. De Vuyst, K. Nackaerts, J. Delanghe, C. Legrand, J. P. van Meerbeeck (Ghent, Kapelle-op-den-Bos, Brussels, Leuven, Louvain-la-Neuve, Belgium). Soluble mesothelin as an early diagnostic tool in asbestos-exposed workers. Eur Respir J 2009; 34: Suppl. 53, 1919

Member's Comments

No comment yet.

Related content which might interest you: Soluble mesothelin as a monitoring tool for malignant mesothelioma patients Source: Annual Congress 2009 - New insights in biology and treatment of pleural tumours Year: 2009 Screening of asbestos-exposed individuals using mesothelioma biomarkers Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions Year: 2010 Utility of serum soluble mesothelin as a follow-up marker in patients with malignant pleural mesothelioma Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007 Serum KL-6, SP-D and MMP-2 as diagnostic biomarkers in asbestosis and silicosis Source: International Congress 2017 – Silicosis has not gone away Year: 2017 Pro-GRP as a diagnostic tool in SCLC in comparison to NSE Source: Eur Respir J 2002; 20: Suppl. 38, 231s Year: 2002 Hyaluronan: A novel sputum marker for the screening and diagnosis of lung cancer patients Source: Annual Congress 2012 - Early detection of lung cancer Year: 2012 Serum napsin A is a novel diagnostic and monitoring marker for interstitial lung disease Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011 Serum thioredoxin-1 as a diagnostic marker for malignant peritoneal mesothelioma Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012 KL-6 is a useful serum biomarker for early detection of interstitial lung disease Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012 Evaluating the utility of mesothelin in diagnosing mesothelioma Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013 High performance and timely care of integrated FDG-PET and diagnostic CT in a rapid outpatient diagnostic program for suspected lung cancer patients Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 Are FENO indices useful diagnostic tools in suspected asthma? Experience of a routine lung function laboratory Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Serum KL-6 as a biomarker for interstitial lung diseases in a clinical setting: application of a fully automated immunoassay. Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 The serum YKL-40 is a useful biomarker for asthma Source: International Congress 2017 – Techniques to treat asthma Year: 2017 A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions Source: Eur Respir J 2013; 41: 18-24 Year: 2013 Electrophoresis of blood serum: A helpful diagnostic tool for identifying respiratory patients with alpha1-antitrypsin deficiency Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015 Role of progestrin releasing peptide (ProGRP), a serum based biomarker in early diagnosis of SCLC in cohort of high-risk patient presenting with symptoms related to lung cancer Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 The evaluation of serum biomarkers in patients with sarcoidosis: Can visfatin be a new biomarker for sarcoidosis? Source: International Congress 2017 – Rare diseases Year: 2017 Osteopontin and soluble mesothelin-related peptide levels in malignant and benign diseases due to environmental asbestos exposure and healthy people with environmental asbestos exposure Source: Annual Congress 2011 - Environmental exposure and disease mechanisms Year: 2011 Usefulness of procalcitonin as a diagnostic marker of pleural effusion Source: Annual Congress 2012 - Prognostic indices in respiratory infections Year: 2012